Abstract Chimeric antigen receptor (CAR) NK and T cell therapy are promising immunotherapeutic approaches for the treatment of cancer. However. the efficacy of CAR NK/T cell therapy is often hindered by various factors. including the phenomenon of trogocytosis. https://www.roneverhart.com/Nuits-de-Noho-by-Bond-No-9/